Clinical TrialsSearch results
Number of results: 482
Other
- The investigation of prospective memory process with the Cambridge Prospective Memory Test (CAMPROMPT)-Japanese
- Cerebrovascular disease Traumatic brain injury Mild cognitive impairment Alzheimer's disease Frontotemporal dementia Dementia with Lewy bodies
- Kawasaki University of Medical Welfare
- 2009-06-10
Other
- The Intraoperative Landiolol for Intracranial Aneurysm Surgery Trials
- Tachyarrhythmia
- The Intraoperative Landiolol for Intracranial Aneurysm Surgery Trials Group
- 2007-12-15
Other
- The evaluation of the efficacy and safety on Bortezomib and Dexamethasone (BD therapy) using auto-PBSCT treatment after Vincristine,Doxorubicin and examethasone (VAD treatment) registanced multiple myeloma patients.(JMSG-0901)
- Multiple myeloma.
- Japanese Society of Myeloma
- 2009-08-03
Other
- The efficacy of cyclospolin A and low dose mycophenolate mofetil to prevent GVHD for reduced-intensity (fludarabine , cyclophosphamide , total body irradiation) cord blood stem cell transplantation
- Hematologic malignancies
- RICBT Study Group
- 2009-03-06
Other
- The efficacy and feasibility of the repeated intraperitoneal Paclitaxel +systemic TS-1 and Paclitaxel for far advanced or recurrent gastric cancer: Phase I/II trial.
- Far advanced or recurrent gastric cancer
- Department of Surgical Oncology The University of Tokyo
- 2008-08-30
Other
- The clinical significance of circulating tumor cell in metastatic Non-Small Cell Lung Cancer
- metastatic non-small cell lung cancer
- Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University
- 2009-04-18
Other
- The changes of QOL in patients with Alzherimer's disease through medical treatment: an observational study
- Alzheimer's disease
- Non Profit Organization Institute of Community Medicine and Welfare for Central Nervous System
- 2008-07-19
Other
- Teprenone for preventing aggravation of COVID-19
- COVID-19
- ICHIHARA Eiki
- 2020-05-20
Other
- TCD-10214
- Secondary Lymphedema
- Hayashi Shoko
- 2022-12-08
Other
- T-DXd vs. T-DM1 in high-risk HER2-positive patients with residual invasive breast cancer following neoadjuvant therapy
- HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer
- Inoguchi Akihiro
- 2020-12-01